5,835
Views
49
CrossRef citations to date
0
Altmetric
Reviews

Image-guided lung metastasis ablation: a literature review

, , , , , , , , & show all
Pages 37-45 | Received 02 Jun 2019, Accepted 25 Jun 2019, Published online: 20 Sep 2019

References

  • Herold CJ, Bankier AA, Fleischmann D. Lung metastases. Eur Radiol. 1996;6:596–606. http://www.ncbi.nlm.nih.gov/pubmed/8934121 (accessed May 26, 2019).
  • Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624–1633.
  • Mohammed T-LH, Chowdhry A, Reddy GP, et al. Expert panel on thoracic imaging, ACR Appropriateness Criteria® screening for pulmonary metastases. J Thorac Imaging. 2011;26:W1–W3.
  • Casiraghi M, De Pas T, Maisonneuve P, et al. A 10-year single-center experience on 708 lung metastasectomies: the evidence of the international registry of lung metastases. J Thorac Oncol. 2011;6:1373–1378.
  • Sethi N, Kang Y. Unravelling the complexity of metastasis – molecular understanding and targeted therapies. Nat Rev Cancer. 2011;11:735–748.
  • Quirk MT, Pomykala KL, Suh RD. Current readings: percutaneous ablation for pulmonary metastatic disease. Semin Thorac Cardiovasc Surg. 2014;26:239–248.
  • de Baere T, Tselikas L, Gravel G, et al. Lung ablation: best practice/results/response assessment/role alongside other ablative therapies. Clin Radiol. 2017;72:657–664.
  • de Baère T, Aupérin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol Off J Eur Soc Med Oncol. 2015;26:987–991.
  • Pastorino U, Buyse M, Friedel G, et al. International registry of lung metastases, long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37–49. http://www.ncbi.nlm.nih.gov/pubmed/9011700 (accessed May 26, 2019).
  • Patel IJ, Davidson JC, Nikolic B, Standards of Practice Committee, with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23:727–736.
  • Pereira PL, Salvatore M, Salvatore M, Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors. Cardiovasc Intervent Radiol. 2012;35:247–254.
  • Hess A, Palussière J, Goyers J-F, et al. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011;258:635–642.
  • Grieco CA, Simon CJ, Mayo-Smith WW, et al. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol. 2006;17:1117–1124.
  • Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174:57–59.
  • Hiraki T, Mimura H, Gobara H, et al. Two cases of needle-tract seeding after percutaneous radiofrequency ablation for lung cancer. J Vasc Interv Radiol. 2009;20:415–418.
  • Vogl TJ, Nour-Eldin N-EA, Hammerstingl RM, et al. Microwave ablation (MWA): basics, technique and results in primary and metastatic liver neoplasms - review article. Fortschr Röntgenstr. 2017;189:1055–1066.
  • Wright AS, Lee FT, Mahvi DM. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol. 2003;10:275–283.
  • Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology. 2009;251:933–940.
  • Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol. 2009;38:135–143.
  • Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247:871–879.
  • Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174:323–331.
  • Yang D, Converse MC, Mahvi DM, et al. Measurement and analysis of tissue temperature during microwave liver ablation. IEEE Trans Biomed Eng. 2007;54:150–155.
  • Brace CL. Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol. 2009;38:61.
  • Ye X, Fan W, Chen J, et al. Chinese expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer. 2015;6:112–121.
  • de Freitas RMC, Andrade CS, Caldas JGMP, et al. Image-guided cryoablation of the spine in a swine model: clinical, radiological, and pathological findings with light and electron microscopy. Cardiovasc Intervent Radiol. 2015;38:1261–1270.
  • Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171–186.
  • Guan L, Wang J, Gao K, et al. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction: a case report and review of the literature. J Cancer Res Ther. 2016;12:221–224.
  • Waitz R, Solomon SB, Petre EN, et al. Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Cancer Res. 2012;72:430–439.
  • Littrup PJ, Mody A, Sparschu R, et al. Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model. Urology. 1994;44:175–183.
  • de Baere T, Tselikas L, Woodrum D, et al. Evaluating cryoablation of metastatic lung tumors in patients-safety and efficacy: the ECLIPSE Trial-interim analysis at 1 year. J Thorac Oncol. 2015;10:1468–1474.
  • Hinshaw JL, Littrup PJ, Durick N, et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol. 2010;33:1180–1185.
  • Ito N, Nakatsuka S, Inoue M, et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol. 2012;23:1043–1052.
  • Silk M, Tahour D, Srimathveeravalli G, et al. The state of irreversible electroporation in interventional oncology. Semin Intervent Radiol. 2014;31:111–117.
  • Coster HGL. A quantitative analysis of the voltage-current relationships of fixed charge membranes and the associated property of ‘punch-through’. Biophys J. 1965;5:669–686.
  • Davalos RV, Mir ILM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223–231.
  • Breton M, Mir LM. Microsecond and nanosecond electric pulses in cancer treatments. Bioelectromagnetics. 2012;33:106–123.
  • Charpentier KP, Wolf F, Noble L, et al. Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford). 2011;13:168–173.
  • Schoellnast H, Monette S, Ezell PC, et al. Acute and subacute effects of irreversible electroporation on nerves: experimental study in a pig model. Radiology. 2011;260:421–427.
  • Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg. 2010;211:68–72.
  • Chen C-K, Chou T-Y, Chen C-B, et al. Image-guided cryoablation for metastatic diaphragmatic thymoma. J Vasc Interv Radiol. 2012;23:1097–1099.
  • Stuchly MA, Athey TW, Stuchly SS, et al. Dielectric properties of animal tissues in vivo at frequencies 10 MHz–1 GHz. Bioelectromagnetics. 1981;2:93–103.
  • de Baere T. New techniques of tumor ablation (microwaves, electroporation)]. J Radiol. 2011;92:789–795.
  • de Baere T, Tselikas L, Pearson E, et al. Interventional oncology for liver and lung metastases from colorectal cancer: the current state of the art. Diagn Interv Imaging. 2015;96:647–654.
  • Pescatori LC, Torcia P, Nicosia L, et al. Which needle in the treatment of thyroid nodules? Gland Surg. 2018;7:111.
  • De Filippo M, Russo U, Papapietro VR, et al. Radiofrequency ablation of osteoid osteoma. Acta Biomed. 2018;89:175–185.
  • Higgins LJ, Hong K. Renal ablation techniques: state of the art. AJR Am J Roentgenol. 2015;205:735–741.
  • Havez M, Lippa N, Al-Ammari S, et al. Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Intervent Radiol. 2014;37:1500–1506.
  • O’Brien TJ, Passeri M, Lorenzo MF, et al. Experimental high-frequency irreversible electroporation using a single-needle delivery approach for nonthermal pancreatic ablation in vivo. J Vasc Interv Radiol. 2019;30:854–862.e7.
  • Vroomen LGPH, Petre EN, Cornelis FH, et al. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: what are the differences? Diagn Interv Imaging. 2017;98:609–617.
  • Kim HJ, Park BK, Chung IS. Comparison of general anesthesia and conscious sedation during computed tomography-guided radiofrequency ablation of T1a renal cell carcinoma. Can Assoc Radiol J. 2018;69:24–29.
  • Gazzera C, Fonio P, Faletti R, et al. Role of paravertebral block anaesthesia during percutaneous transhepatic thermoablation. Radiol Med. 2014;119:549–557.
  • Palussière J, Catena V, Gaubert J-Y, et al. Percutaneous lung thermo-ablation. Bull Cancer. 2017;104:417–422.
  • Sharma A, Abtin F, Shepard J-AO. Image-guided ablative therapies for lung cancer. Radiol Clin North Am. 2012;50:975–999.
  • Cazzato RL, Battistuzzi J-B, Catena V, et al. Cone-beam computed tomography (CBCT) versus CT in lung ablation procedure: which is faster? Cardiovasc Intervent Radiol. 2015;38:1231–1236.
  • Mauri G, Gennaro N, De Beni S, et al. Real-time US-18FDG-PET/CT image fusion for guidance of thermal ablation of 18FDG-PET-positive liver metastases: the added value of contrast enhancement. Cardiovasc Intervent Radiol. 2019;42:60–68.
  • Mauri G. Expanding role of virtual navigation and fusion imaging in percutaneous biopsies and ablation. Abdom Imaging. 2015;40:3238–3239.
  • Mauri G, Solbiati L. Virtual navigation and fusion imaging in percutaneous ablations in the neck. Ultrasound Med Biol. 2015;41:898.
  • Mauri G, Cova L, De Beni S, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38:143–151.
  • de Baère T, Palussière J, Aupérin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240:587–596.
  • Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230:125–134.
  • Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015–1024.
  • Kashima M, Yamakado K, Takaki H, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. AJR Am J Roentgenol. 2011;197:W576–W580.
  • Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241:275–283.
  • Abtin FG, Eradat J, Gutierrez AJ, et al. Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics. 2012;32:947–969.
  • Jin GY, Lee JM, Lee YC, et al. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol. 2004;183:1013–1020.
  • Palussière J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol. 2011;34:989–997.
  • Bonichon F, Palussière J, Godbert Y, et al. Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study. Eur J Nucl Med Mol Imaging. 2013;40:1817–1827.
  • Deandreis D, Leboulleux S, Dromain C, et al. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology. 2011;258:270–276.
  • Hiraki T, Gobara H, Mimura H, et al. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2011;142:24–30.
  • Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621–628.
  • de Baere T, Robinson JM, Rao P, et al. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience. J Vasc Interv Radiol. 2011;22:749–754.
  • Nour-Eldin N-EA, Exner S, Al-Subhi M, et al. Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA). Int J Hyperthermia. 2017;33:820–829.
  • Ricke J, Jürgens JHW, Deschamps F, et al. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol. 2015;38:401–408.